Industrial & Academic Collaborations
Roche – Phase I trial BDB001 + atezolizumab (anti-PD-L1)
Merck (MSD) – Phase I trial BDB001 + pembrolizumab (anti-PD-1)
Bergonie
Roche – Phase I trial BDB001 + atezolizumab (anti-PD-L1)
Merck (MSD) – Phase I trial BDB001 + pembrolizumab (anti-PD-1)
Bergonie